Reactivation of Runx1 after MI therefore plays a crucial role in excitation-contraction coupling and adverse cardiac remodeling and represents a new therapeutic target with the potential to limit progression to heart failure among patients with MI. The gene discussed is RUNX1; the disease is heart failure.